Breast cancer patients' personality style, age, and treatment decision making

Journal of Surgical Oncology
J D JohnsonM Parsons

Abstract

Previous studies have shown that whereas nearly all cancer patients want information, far fewer wish to make treatment decisions. Although breast cancer patients who were given a choice of lumpectomy versus mastectomy and were encouraged to make the decision were believed to do better psychologically, a 1994 study refuted this. Some authors suggest that patient personality style is an important consideration in decisional preference. Newly diagnosed breast cancer patients (n = 76) were surveyed within 6 months of surgery. They answered seven questions about patient and physician roles in the decision-making process. Additionally, they completed the Miller Behavioral Style Scale (MBSS), which categorizes "monitors," or information seekers, and "blunters," or information avoiders. Chi-square analyses were used to explore the relationship of personality style and age to treatment decision-making preferences. Although 80% of women wanted a role in decision making, 74% wanted their surgeons to make a recommendation and when given, 94% followed the recommended treatment plan. Monitors and blunters were equally likely to want physician recommendations. Younger women, particularly those under age 40, were more likely to want a physicia...Continue Reading

Associated Clinical Trials

References

Sep 1, 1992·Journal of Clinical Epidemiology·L F Degner, J A Sloan
Mar 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M LevyT d'Angelo
Jan 1, 1988·Social Science & Medicine·C G BlanchardE B Blanchard
Jan 1, 1988·Journal of Personality and Social Psychology·S M MillerJ Summerton
Dec 7, 1984·JAMA : the Journal of the American Medical Association·W M StrullG Charles
Apr 10, 1980·The New England Journal of Medicine·I D Goldberg, M B Stemerman
Apr 17, 1980·The New England Journal of Medicine·B R CassilethV March

❮ Previous
Next ❯

Citations

May 20, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Gill HubbardEdward Donaghy
Jun 29, 2010·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Stephanie SivellAntony S R Manstead
Jan 3, 2013·Journal of Surgical Oncology·Lesley KingMarc D Schwartz
Sep 8, 2005·The Journal of Urology·Holly J RamsawhWilliam C DeWolf
May 17, 2011·Patient Education and Counseling·Stephanie SivellUNKNOWN BresDex group
Jun 24, 2004·International Journal of Technology Assessment in Health Care·Laura Sampietro-ColomAngela B Hutchinson
Jul 11, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Abraham N MorseStephen B Young
Jul 20, 2006·Breast Cancer Research and Treatment·Brenda SaboDaniel Rayson
Nov 23, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A M StiggelboutC J H van de Velde
Jun 27, 2006·Pathology Oncology Research : POR·Zsuzsanna KahánLászló Thurzó
Feb 4, 2014·Journal of Behavioral Medicine·Pagona Roussi, Suzanne M Miller
Nov 1, 2002·Medical Care·Daniel PolskyKevin A Schulman
Oct 12, 1999·Breast Cancer Research and Treatment·S E TropmanT Aldrich
Feb 27, 2001·Journal of Surgical Oncology·S BenedictP Baron
Aug 14, 2020·BMC Medical Informatics and Decision Making·Laura A ShinkunasErica M Carlisle
Aug 15, 2000·Research in Nursing & Health·B J Garvin, C J Kim
Oct 1, 2002·Journal of Genetic Counseling·Duane D CullerJoann Bodurtha
Jun 5, 2020·Annals of Surgical Oncology·Lily GutnikCindy B Matsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.